In a major escalation of its ongoing legal and financial crisis, Bayer is reportedly preparing to settle thousands of lawsuits involving its controversial Roundup weedkiller – and is even considering bankruptcy for its Monsanto subsidiary if these efforts fail. News of this development, revealed by The Wall Street Journal, preceded a Missouri appellate court delivering a crushing blow to the company: the upholding of a $611 million verdict for three plaintiffs who developed cancer after using the weedkiller.
Bayer, which acquired Monsanto for $63 billion in 2018, has already paid out roughly $10 billion to settle earlier claims linking glyphosate – the active ingredient in Roundup – to cancer. But the German pharmaceutical and chemical giant still faces around 67,000 unresolved lawsuits across state and federal courts in the United States. The latest ruling by the Missouri Court of Appeals’ Western District rejected Monsanto’s attempt to overturn the verdict in a case that had consolidated the claims of three individuals who developed non-Hodgkin’s lymphoma after prolonged exposure to Roundup.
While Bill Anderson is claiming he will somehow be able to “significantly contain” glyphosate litigation by the end of 2026, the fact is that, with tens of thousands of lawsuits still outstanding, Bayer remains in deep trouble.
To learn more about the background to this news story, see this article on our website.
COVID-19 Vaccines ‘Saved Far Fewer Lives Than First Thought’
August 22, 2025Fauci’s Great Escape: Explosive Wuhan Claim Stalks COVID-19 Czar… But He Still Walks Free
August 22, 2025Bayer CEO’s Dark Plot to ‘Silence’ Thousands of Cancer Victims
News
Bayer pharmaceuticals’ chief executive, Bill Anderson, is under fire after a damning report accused the $60 billion biotech giant of trying to rewrite the law to avoid tens of thousands of cancer lawsuits linked to its Roundup weed killer.
[Source: abdpost.com]
[Image source: Wikimedia]
Comment
In a major escalation of its ongoing legal and financial crisis, Bayer is reportedly preparing to settle thousands of lawsuits involving its controversial Roundup weedkiller – and is even considering bankruptcy for its Monsanto subsidiary if these efforts fail. News of this development, revealed by The Wall Street Journal, preceded a Missouri appellate court delivering a crushing blow to the company: the upholding of a $611 million verdict for three plaintiffs who developed cancer after using the weedkiller.
Bayer, which acquired Monsanto for $63 billion in 2018, has already paid out roughly $10 billion to settle earlier claims linking glyphosate – the active ingredient in Roundup – to cancer. But the German pharmaceutical and chemical giant still faces around 67,000 unresolved lawsuits across state and federal courts in the United States. The latest ruling by the Missouri Court of Appeals’ Western District rejected Monsanto’s attempt to overturn the verdict in a case that had consolidated the claims of three individuals who developed non-Hodgkin’s lymphoma after prolonged exposure to Roundup.
While Bill Anderson is claiming he will somehow be able to “significantly contain” glyphosate litigation by the end of 2026, the fact is that, with tens of thousands of lawsuits still outstanding, Bayer remains in deep trouble.
To learn more about the background to this news story, see this article on our website.
Dr. Rath Health Foundation
Related posts
Health Officials to Examine if Drugs Used to Treat Parkinson’s Can Lead to Addiction Issues
Read more